Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Creating a specialist physician workforce in low-resource settings: reflections and lessons learnt from the East African Training Initiative.

Schluger NW, Sherman CB, Binegdie A, Gebremariam T, Kebede D, Worku A, Carter EJ, Brändli O.

BMJ Glob Health. 2018 Sep 17;3(5):e001041. doi: 10.1136/bmjgh-2018-001041. eCollection 2018.

2.

Factors associated with cessation of smoking among Swiss adults between 1991 and 2011: results from the SAPALDIA cohort.

Ayala-Bernal D, Probst-Hensch N, Rochat T, Bettschart R, Brändli O, Bridevaux PO, Burdet L, Frey M, Gerbase M, Pons M, Rothe T, Stolz D, Tschopp JM, Turk A, Künzli N, Schindler C.

Swiss Med Wkly. 2017 Oct 6;147:w14502. doi: 10.4414/smw.2017.14502. eCollection 2017.

3.

Tuberkulose heute.

Brändli O.

Rev Med Suisse. 2017 Jan 25;13(547):186-188. German. No abstract available.

PMID:
28703968
4.

Wie können wir die Lebensqualität von Patienten mit COPD verbessern?

Brändli O.

Praxis (Bern 1994). 2017;106(11):579-582. doi: 10.1024/1661-8157/a002691. German. No abstract available.

PMID:
28537121
5.

An official American Thoracic Society workshop report: Climate change and human health.

Pinkerton KE, Rom WN, Akpinar-Elci M, Balmes JR, Bayram H, Brandli O, Hollingsworth JW, Kinney PL, Margolis HG, Martin WJ, Sasser EN, Smith KR, Takaro TK; American Thoracic Society Environmental Health Policy Committee.

Proc Am Thorac Soc. 2012 Mar;9(1):3-8. doi: 10.1513/pats.201201-015ST.

6.

Early versus late pulmonary rehabilitation in chronic obstructive pulmonary disease patients with acute exacerbations: a randomized trial.

Puhan MA, Spaar A, Frey M, Turk A, Brändli O, Ritscher D, Achermann E, Kaelin R, Karrer W.

Respiration. 2012;83(6):499-506. doi: 10.1159/000329884. Epub 2011 Aug 16.

7.

[Tuberculosis in Switzerland].

Brändli O, Zellweger JP.

Ther Umsch. 2011 Jul;68(7):365-8. doi: 10.1024/0040-5930/a000178. Review. German.

PMID:
21728153
8.

[Latent tuberculosis].

Bonomo C, Brändli O, Rampini SK.

Praxis (Bern 1994). 2011 Feb 2;100(3):125-36. doi: 10.1024/1661-8157/a000432. German. No abstract available.

PMID:
21290367
9.

[Smoking history worldwide--cigarette smoking, passive smoking and smoke free environment in Switzerland].

Brändli O.

Ther Umsch. 2010 Aug;67(8):391-8. doi: 10.1024/0040-5930/a000069. German.

PMID:
20687040
10.

Longitudinal change of prebronchodilator spirometric obstruction and health outcomes: results from the SAPALDIA cohort.

Probst-Hensch NM, Curjuric I, Pierre-Olivier B, Ackermann-Liebrich U, Bettschart RW, Brändli O, Brutsche M, Burdet L, Gerbase MW, Knöpfli B, Künzli N, Pons MG, Schindler C, Tschopp JM, Rochat T, Russi EW.

Thorax. 2010 Feb;65(2):150-6. doi: 10.1136/thx.2009.115063. Epub 2009 Dec 8.

PMID:
19996350
11.

Improvements in PM10 exposure and reduced rates of respiratory symptoms in a cohort of Swiss adults (SAPALDIA).

Schindler C, Keidel D, Gerbase MW, Zemp E, Bettschart R, Brändli O, Brutsche MH, Burdet L, Karrer W, Knöpfli B, Pons M, Rapp R, Bayer-Oglesby L, Künzli N, Schwartz J, Liu LJ, Ackermann-Liebrich U, Rochat T; SAPALDIA Team.

Am J Respir Crit Care Med. 2009 Apr 1;179(7):579-87. doi: 10.1164/rccm.200803-388OC. Epub 2009 Jan 16.

PMID:
19151198
12.

Effect of physical activity on heart rate variability in normal weight, overweight and obese subjects: results from the SAPALDIA study.

Felber Dietrich D, Ackermann-Liebrich U, Schindler C, Barthélémy JC, Brändli O, Gold DR, Knöpfli B, Probst-Hensch NM, Roche F, Tschopp JM, von Eckardstein A, Gaspoz JM; Sapaldia team.

Eur J Appl Physiol. 2008 Oct;104(3):557-65. doi: 10.1007/s00421-008-0800-0. Epub 2008 Jul 3.

13.

SERPINA1 gene variants in individuals from the general population with reduced alpha1-antitrypsin concentrations.

Zorzetto M, Russi E, Senn O, Imboden M, Ferrarotti I, Tinelli C, Campo I, Ottaviani S, Scabini R, von Eckardstein A, Berger W, Brändli O, Rochat T, Luisetti M, Probst-Hensch N; SAPALDIA Team.

Clin Chem. 2008 Aug;54(8):1331-8. doi: 10.1373/clinchem.2007.102798. Epub 2008 May 29.

14.

Circulating alpha1-antitrypsin in the general population: determinants and association with lung function.

Senn O, Russi EW, Schindler C, Imboden M, von Eckardstein A, Brändli O, Zemp E, Ackermann-Liebrich U, Berger W, Rochat T, Luisetti M, Probst-Hensch NM; SAPALDIA Team.

Respir Res. 2008 Apr 25;9:35. doi: 10.1186/1465-9921-9-35.

15.

Reference equations for lung function screening of healthy never-smoking adults aged 18-80 years.

Kuster SP, Kuster D, Schindler C, Rochat MK, Braun J, Held L, Brändli O.

Eur Respir J. 2008 Apr;31(4):860-8. Epub 2007 Dec 5.

16.

Ultrafine particle emissions from waterpipes.

Monn Ch, Kindler P, Meile A, Brändli O.

Tob Control. 2007 Dec;16(6):390-3.

17.

Effects of passive smoking on heart rate variability, heart rate and blood pressure: an observational study.

Felber Dietrich D, Schwartz J, Schindler C, Gaspoz JM, Barthélémy JC, Tschopp JM, Roche F, von Eckardstein A, Brändli O, Leuenberger P, Gold DR, Ackermann-Liebrich U; SAPALDIA-team.

Int J Epidemiol. 2007 Aug;36(4):834-40. Epub 2007 Apr 17.

PMID:
17440032
18.

Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALDIA cohort study.

Imboden M, Downs SH, Senn O, Matyas G, Brändli O, Russi EW, Schindler C, Ackermann-Liebrich U, Berger W, Probst-Hensch NM; SAPALDIA Team.

Respir Res. 2007 Jan 11;8:2.

19.

[Farewell to a pioneer in the campaign against tuberculosis. Prof. Dr. med. Eduard Haeflinger].

Brändli O.

Praxis (Bern 1994). 2006 Oct 11;95(41):1573. German. No abstract available.

PMID:
17080757
20.

Respiratory effects of environmental tobacco exposure are enhanced by bronchial hyperreactivity.

Gerbase MW, Schindler C, Zellweger JP, Künzli N, Downs SH, Brändli O, Schwartz J, Frey M, Burdet L, Rochat T, Ackermann-Liebrich U, Leuenberger P; SAPALDIA Team.

Am J Respir Crit Care Med. 2006 Nov 15;174(10):1125-31. Epub 2006 Aug 24.

21.

Heart rate variability in an ageing population and its association with lifestyle and cardiovascular risk factors: results of the SAPALDIA study.

Felber Dietrich D, Schindler C, Schwartz J, Barthélémy JC, Tschopp JM, Roche F, von Eckardstein A, Brändli O, Leuenberger P, Gold DR, Gaspoz JM, Ackermann-Liebrich U; SAPALDIA Team.

Europace. 2006 Jul;8(7):521-9.

PMID:
16798766
22.

Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study.

Nitsch D, Felber Dietrich D, von Eckardstein A, Gaspoz JM, Downs SH, Leuenberger P, Tschopp JM, Brändli O, Keller R, Gerbase MW, Probst-Hensch NM, Stutz EZ, Ackermann-Liebrich U; SAPALDIA team.

Nephrol Dial Transplant. 2006 Apr;21(4):935-44. Epub 2006 Jan 3.

23.

Reference values for methacholine reactivity (SAPALDIA study).

Jayet PY, Schindler C, Künzli N, Zellweger JP, Brändli O, Perruchoud AP, Keller R, Schwartz J, Ackermann-Liebrich U, Leuenberger P; SAPALDIA team.

Respir Res. 2005 Nov 4;6:131.

24.

Longitudinal validity of spirometers--a challenge in longitudinal studies.

Künzli N, Kuna-Dibbert B, Keidel D, Keller R, Brändli O, Schindler C, Schweinzer KM, Leuenberger P, Ackermann-Liebrich U; SAPALDIA team.

Swiss Med Wkly. 2005 Aug 20;135(33-34):503-8.

25.

Follow-up of the Swiss Cohort Study on Air Pollution and Lung Diseases in Adults (SAPALDIA 2) 1991-2003: methods and characterization of participants.

Ackermann-Liebrich U, Kuna-Dibbert B, Probst-Hensch NM, Schindler C, Felber Dietrich D, Stutz EZ, Bayer-Oglesby L, Baum F, Brändli O, Brutsche M, Downs SH, Keidel D, Gerbase MW, Imboden M, Keller R, Knöpfli B, Künzli N, Nicod L, Pons M, Staedele P, Tschopp JM, Zellweger JP, Leuenberger P; SAPALDIA Team.

Soz Praventivmed. 2005;50(4):245-63.

26.

Pulmonary Mycobacterium sherrisii infection in a human immunodeficiency virus type 1-infected patient.

Gämperli A, Bosshard PP, Sigrist T, Brändli O, Wildermuth S, Weber R, Mueller NJ.

J Clin Microbiol. 2005 Aug;43(8):4283-5.

27.

Accelerated decline in lung function in smoking women with airway obstruction: SAPALDIA 2 cohort study.

Downs SH, Brändli O, Zellweger JP, Schindler C, Künzli N, Gerbase MW, Burdet L, Bettschart R, Zemp E, Frey M, Keller R, Tschopp JM, Leuenberger P, Ackermann-Liebrich U; SAPALDIA team.

Respir Res. 2005 May 26;6:45.

28.

Self-administration and standardisation of the chronic respiratory questionnaire: a randomised trial in three German-speaking countries.

Puhan MA, Behnke M, Laschke M, Lichtenschopf A, Brändli O, Guyatt GH, Schünemann HJ.

Respir Med. 2004 Apr;98(4):342-50.

29.

Self-administration and interviewer-administration of the German Chronic Respiratory Questionnaire: instrument development and assessment of validity and reliability in two randomised studies.

Puhan MA, Behnke M, Frey M, Grueter T, Brandli O, Lichtenschopf A, Guyatt GH, Schunemann HJ.

Health Qual Life Outcomes. 2004 Jan 8;2:1.

30.

Smoke-free cafe in an unregulated European city: highly welcomed and economically successful.

Künzli N, Mazzoletti P, Adam M, Götschi T, Mathys P, Monn C, Brändli O.

Tob Control. 2003 Sep;12(3):282-8.

31.

[Pulmonary rehabilitation of COPD in Switzerland--an assessment of current status].

Puhan M, Koller M, Brändli O, Steurer J.

Praxis (Bern 1994). 2003 Jan 22;92(4):111-6. German.

PMID:
12632841
32.

Preliminary validation of PRISM (Pictorial Representation of Illness and Self Measure) - a brief method to assess suffering.

Büchi S, Buddeberg C, Klaghofer R, Russi EW, Brändli O, Schlösser C, Stoll T, Villiger PM, Sensky T.

Psychother Psychosom. 2002 Nov-Dec;71(6):333-41.

PMID:
12411768
33.

Management of chronic obstructive pulmonary disease: the Swiss guidelines. Official Guidelines of the Swiss Respiratory Society.

Russi EW, Leuenberger P, Brändli O, Frey JG, Grebski E, Gugger M, Paky A, Pons M, Karrer W, Kuhn M, Rochat T, Schibli R, Solèr M, Wacker J.

Swiss Med Wkly. 2002 Feb 9;132(5-6):67-78. Review. No abstract available.

34.

[Overweight and obesity in the Zurich canton. A LuftiBus study].

Egger S, Wieland R, Ludin M, Brändli O, Vetter W, Suter PM.

Praxis (Bern 1994). 2001 Mar 29;90(13):531-8. German.

PMID:
11550618
35.

[Recommendations for updated lung function reference values from the SAPALDIA study].

Degens P, Baur X, Brändli O, Schindler C.

Pneumologie. 2000 Dec;54(12):596-603. German. No abstract available.

PMID:
11199121
36.

Occupational exposure to inhalative irritants and methacholine responsiveness.

Leuenberger P, Schindler C, Schwartz J, Ackermann-Liebrich U, Tara D, Perruchoud AP, Wüthrich B, Zellweger JP, Blaser K, Bolognini G, Bongard JP, Brändli O, Domenighetti G, Elsasser S, Grizé L, Karrer W, Keller R, Künzli N, Medici T, Schöni MH, Solari G, Tschopp JM, Villiger B, Zemp E.

Scand J Work Environ Health. 2000 Apr;26(2):146-52.

37.

[Inpatient rehabilitation in inpatients with chronic obstructive lung diseases (COPD): effect on physical capacity for work, psychological wellbeing and quality of life].

Büchi S, Brändli O, Klingler K, Klaghofer R, Buddeberg C.

Schweiz Med Wochenschr. 2000 Feb 5;130(5):135-42. German.

PMID:
10701230
38.

Re-estimated equations for 5th percentiles of lung function variables.

Brändli O, Schindler C, Leuenberger PH, Baur X, Degens P, Künzli N, Keller R, Perruchoud AP.

Thorax. 2000 Feb;55(2):173-4. No abstract available.

39.

Clinically "small" effects of air pollution on FVC have a large public health impact. Swiss Study on Air Pollution and Lung Disease in Adults (SAPALDIA) - team.

Künzli N, Ackermann-Liebrich U, Brändli O, Tschopp JM, Schindler C, Leuenberger P.

Eur Respir J. 2000 Jan;15(1):131-6.

40.

Peak flow variability in the SAPALDIA study and its validity in screening for asthma-related conditions. The SPALDIA Team.

Künzli N, Stutz EZ, Perruchoud AP, Brändli O, Tschopp JM, Bolognini G, Karrer W, Schindler C, Ackermann-Liebrich U, Leuenberger P.

Am J Respir Crit Care Med. 1999 Aug;160(2):427-34.

PMID:
10430709
41.

Long-term ambient air pollution and respiratory symptoms in adults (SAPALDIA study). The SAPALDIA Team.

Zemp E, Elsasser S, Schindler C, Künzli N, Perruchoud AP, Domenighetti G, Medici T, Ackermann-Liebrich U, Leuenberger P, Monn C, Bolognini G, Bongard JP, Brändli O, Karrer W, Keller R, Schöni MH, Tschopp JM, Villiger B, Zellweger JP.

Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1257-66.

PMID:
10194174
42.
43.

Associations between lung function and estimated average exposure to NO2 in eight areas of Switzerland. The SAPALDIA Team. Swiss Study of Air Pollution and Lung Diseases in Adults.

Schindler C, Ackermann-Liebrich U, Leuenberger P, Monn C, Rapp R, Bolognini G, Bongard JP, Brändli O, Domenighetti G, Karrer W, Keller R, Medici TG, Perruchoud AP, Schöni MH, Tschopp JM, Villiger B, Zellweger JP.

Epidemiology. 1998 Jul;9(4):405-11.

PMID:
9647904
44.

Transmission of tuberculosis in the metropolitan area of Zurich: a 3 year survey based on DNA fingerprinting.

Pfyffer GE, Strässle A, Rose N, Wirth R, Brändli O, Shang H.

Eur Respir J. 1998 Apr;11(4):804-8.

45.

Valvular endocarditis due to Mycobacterium tuberculosis.

Klingler K, Brändli O, Doerfler M, Schluger N, Rom WN.

Int J Tuberc Lung Dis. 1998 May;2(5):435-7.

PMID:
9613642
46.

Personal exposure to nitrogen dioxide in Switzerland. SAPALDIA team. Swiss Study on Air Pollution and Lung Diseases in Adults.

Monn C, Brändli O, Schindler C, Ackermann-Liebrich U, Leuenberger P.

Sci Total Environ. 1998 May 4;215(3):243-51.

PMID:
9606945
47.

The clinical presentation of tuberculosis.

Brändli O.

Respiration. 1998;65(2):97-105. Review. No abstract available.

PMID:
9580919
48.

[Swiss Study on Air Pollution and Lung Diseases in Adults (SAPALDIA)].

Leuenberger P, Künzli N, Ackermann-Liebrich U, Schindler C, Bolognini G, Bongard JP, Brändli O, Defila C, Domenighetti G, Karrer W, Keller R, Medici T, Monn C, Perruchoud AP, Schöni M, Tschopp JM, Villiger B, Wüthrich B, Zellweger JP.

Schweiz Med Wochenschr. 1998 Jan 31;128(5):150-61. French.

PMID:
9522421
49.

Three episodes of tuberculosis--to multidrug resistance and back to susceptibility.

Pfyffer GE, Strässle A, Brändli O, Shang H.

Clin Infect Dis. 1998 Jan;26(1):219-20. No abstract available.

50.

Effects of mycobacteria on regulation of apoptosis in mononuclear phagocytes.

Klingler K, Tchou-Wong KM, Brändli O, Aston C, Kim R, Chi C, Rom WN.

Infect Immun. 1997 Dec;65(12):5272-8.

Supplemental Content

Loading ...
Support Center